Evidence map›Paper›PMID 12743373›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes.

Joseph Lotem, Hilah Gal, Rachel Kama, Ninette Amariglio, Gideon Rechavi, Eytan Domany, Leo Sachs, David Givol

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Induction in myeloid leukemic cells of genes that are expressed in different normal tissues.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Joseph LotemDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Hilah Gal
Rachel Kama
Ninette Amariglio
Gideon Rechavi
Eytan Domany
Leo Sachs
David Givol
Tel Aviv University · ILWeizmann Institute of Science · IL

Funding

NEW METHODS FOR CANCER DETECTIONP01CA065930 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI BARANY, FRANCIS · 1997 to 2007
$14.1M
NCI NIH HHS 5P01CA65930-06NCI NIH HHS P01 CA065930
6 · The paper itself

Abstract

Using DNA microarray and clustering of expressed genes we have analyzed the mechanism of inhibition of wild-type p53-induced apoptosis by the cytokine interleukin 6 (IL-6) and the calcium mobilizer thapsigargin (TG). Clustering analysis of 1,786 genes, the expression level of which changed after activation of wild-type p53 in the absence or presence of IL-6 or TG, showed that these compounds did not cause a general inhibition of the ability of p53 to up-regulate or down-regulate gene expression. Expression of various p53 targets implicated as mediators of p53-induced apoptosis was also not affected by IL-6 or TG. These compounds thus can bypass the effect of wild-type p53 on gene expression and inhibit apoptosis. IL-6 and TG activated different p53-independent pathways of gene expression that include up-regulation of antiapoptotic genes. IL-6 and TG also activated different differentiation-associated genes. The ability of compounds such as cytokines and calcium mobilizers to inhibit p53-mediated apoptosis without generally inhibiting gene expression regulated by p53 can facilitate tumor development and tumor resistance to radiation and chemotherapy in cells that retain wild-type p53.

Indexed as

ApoptosisBase SequenceBlotting, WesternCell DifferentiationCluster AnalysisDNA PrimersGene Expression RegulationInterleukin-6Molecular Sequence DataOligonucleotide Array Sequence AnalysisReverse Transcriptase Polymerase Chain ReactionThapsigarginTumor Cells, CulturedTumor Suppressor Protein p53DNA PrimersInterleukin-6ThapsigarginTumor Suppressor Protein p53

Identifiers

PMID12743373
PMCPMC164513
OpenAlexW2094191572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.